Repligen (RGEN) Short Interest Ratio & Short Volume → The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad) Free RGEN Stock Alerts $171.28 +13.80 (+8.76%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Repligen Short Interest DataCurrent Short Volume4,770,000 sharesPrevious Short Volume4,770,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$877.30 millionShort Interest Ratio / Days to Cover8.8Last Record DateMarch 31, 2024Outstanding Shares55,840,000 sharesFloat Size51,970,000 sharesShort Percent of Float9.18%Today's Trading Volume928,604 sharesAverage Trading Volume538,659 sharesToday's Volume Vs. Average172% Short Selling Repligen ? Sign up to receive the latest short interest report for Repligen and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRGEN Short Interest Over TimeRGEN Days to Cover Over TimeRGEN Percentage of Float Shorted Over Time Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Repligen Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20244,770,000 shares $877.30 million No Change9.2%8.8 $183.92 3/15/20244,770,000 shares $905.97 million -2.3%9.2%8.9 $189.93 2/29/20244,880,000 shares $946.67 million -8.8%9.4%8.1 $193.99 2/15/20245,350,000 shares $1.10 billion -7.9%10.3%8.8 $206.03 1/31/20245,810,000 shares $1.10 billion -0.2%11.2%9.8 $189.40 1/15/20245,820,000 shares $1.01 billion -2.7%11.2%8.7 $173.21 Get the Latest News and Ratings for RGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Repligen and its competitors with MarketBeat's FREE daily newsletter. 12/31/20235,980,000 shares $1.08 billion -2.1%11.5%8.7 $179.80 12/15/20236,110,000 shares $1.11 billion +1.8%11.8%9.1 $181.22 11/30/20236,000,000 shares $943.50 million +0.2%11.6%9.1 $157.25 11/15/20235,990,000 shares $934.02 million +0.3%11.5%9.7 $155.93 10/31/20235,970,000 shares $803.32 million -0.2%11.5%9.9 $134.56 10/15/20235,980,000 shares $913.39 million +2.2%11.5%11.5 $152.74 9/30/20235,850,000 shares $930.21 million +6.2%11.3%11.6 $159.01 9/15/20235,510,000 shares $911.91 million +1.3%10.6%10 $165.50 8/31/20235,440,000 shares $946.07 million +0.7%10.5%9.5 $173.91 8/15/20235,400,000 shares $934.42 million -1.8%10.4%8.9 $173.04 7/31/20235,500,000 shares $943.58 million +2.0%10.6%9.1 $171.56 7/15/20235,390,000 shares $811.14 million +0.9%10.4%8.4 $150.49 6/30/20235,340,000 shares $755.40 million -8.6%10.3%9 $141.46 6/15/20235,840,000 shares $940.59 million +5.0%11.3%10.5 $161.06 5/31/20235,560,000 shares $933.64 million +4.9%10.7%10.2 $167.92 5/15/20235,300,000 shares $816.36 million -1.1%10.2%9.1 $154.03 4/30/20235,360,000 shares $812.74 million +10.1%10.4%9.2 $151.63 4/15/20234,870,000 shares $847.53 million +9.2%9.4%8.7 $174.03 3/31/20234,460,000 shares $750.89 million +7.7%8.6%8.2 $168.36 3/15/20234,140,000 shares $706.62 million No Change8.0%7.5 $170.68 2/28/20234,140,000 shares $721.89 million +9.2%8.0%7.7 $174.37 2/15/20233,790,000 shares $742.84 million -6.4%7.3%6.5 $196.00 1/31/20234,050,000 shares $750.47 million -0.5%7.9%7.3 $185.30 1/15/20234,070,000 shares $724.70 million +11.2%7.9%6.9 $178.06 12/30/20223,660,000 shares $619.67 million +2.0%7.1%5.7 $169.31 12/15/20223,590,000 shares $604.02 million +11.5%7.0%5.7 $168.25 11/30/20223,220,000 shares $575.86 million -0.9%6.2%5 $178.84 11/15/20223,250,000 shares $685.23 million +4.2%6.3%5.7 $210.84 10/31/20223,120,000 shares $569.37 million +5.1%6.0%5.7 $182.49 10/15/20222,970,000 shares $574.81 million +11.7%5.8%5.2 $193.54 9/30/20222,660,000 shares $497.71 million +0.8%5.2%4.9 $187.11 9/15/20222,640,000 shares $613.06 million +1.2%5.1%5.1 $232.22 8/31/20222,610,000 shares $572.56 million -7.8%5.1%4.9 $219.37 8/15/20222,830,000 shares $723.72 million -12.4%5.5%5.3 $255.73The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. RGEN Short Interest - Frequently Asked Questions What is Repligen's current short interest? Short interest is the volume of Repligen shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 4,770,000 shares of RGEN short. 9.18% of Repligen's shares are currently sold short. Learn More on Repligen's current short interest. What is a good short interest ratio for Repligen? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGEN shares currently have a short interest ratio of 9.0. Learn More on Repligen's short interest ratio. Which institutional investors are shorting Repligen? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Repligen: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Repligen? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.18% of Repligen's floating shares are currently sold short. What is Repligen's float size? Repligen currently has issued a total of 55,840,000 shares. Some of Repligen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Repligen currently has a public float of 51,970,000 shares. How does Repligen's short interest compare to its competitors? 9.18% of Repligen's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Repligen: Exelixis, Inc. (2.32%), Neurocrine Biosciences, Inc. (2.44%), Halozyme Therapeutics, Inc. (6.28%), Adaptive Biotechnologies Co. (6.57%), Biogen Inc. (2.46%), Qiagen (1.62%), Bio-Techne Co. (3.38%), Vaxcyte, Inc. (7.59%), Revolution Medicines, Inc. (7.29%), CRISPR Therapeutics AG (17.39%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Repligen stock? Short selling RGEN is an investing strategy that aims to generate trading profit from Repligen as its price is falling. RGEN shares are trading up $13.80 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Repligen? A short squeeze for Repligen occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RGEN, which in turn drives the price of the stock up even further. How often is Repligen's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGEN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Exelixis Short Interest Neurocrine Biosciences Short Interest Halozyme Therapeutics Short Interest Adaptive Biotechnologies Short Interest Biogen Short Interest Qiagen Short Interest Bio-Techne Short Interest Vaxcyte Short Interest Revolution Medicines Short Interest CRISPR Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RGEN) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsBiden out June 13; Kamala won’t replace him?Paradigm Press